FOUNDATION FOR BURKITT LYMPHOMA RESEARCH

The Foundation for Burkitt Lymphoma Research (FFBLR) was established in September 2009 in Geneva, Switzerland by Dr. Jean Paul Martin and Dr. Marie-Reine Martin. They took this decision because their son Xavier Martin was diagnosed with Burkitt Lymphoma (BL), and subsequently passed away from a relapse of the disease in May 2010... The Foundation for Burkitt Lymphoma Research has established a collaborative effort with the National Cancer Institute (NCI), in order to develop a genomic databank for Burkitt Lymphoma. The Burkitt Lymphoma Genome Sequencing Project (BLGSP) will compile genetic changes present in BL tumors, analyze the data to identify diagnostic, prognostic, or therapeutic markers or targets, and publish the results. As with other cancer sequencing projects, the goal is to identify potential genetic changes in patients with BL that could lead to better prevention, detection and treatment of the cancer.